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Introduction
Little is known about pancreatic enzyme levels in the
neurosurgery intensive care unit (ICU). Although a
number of related issues have emerged in the general
ICU, some of which remain unclear,1,2 clinically, we
still use the concepts derived from the general ICU 
to manage neurosurgical patients who have elevated
pancreatic enzymes. Bouwman et al noted that hyper-
amylasemia may be a result of intracranial bleeding.3
Severe head injury can activate pathways that increase
amylase levels in the blood, suggesting central nerv-
ous system regulation of serum amylase levels.4 The
purpose of this study was to look at the effects of 
elevated pancreatic enzymes in the neurosurgical ICU.
Two issues that need to be resolved are: (1) whether
we can assess the specific characteristics of this group
of patients with elevated pancreatic enzymes; and (2)
whether we can incorporate such information into the
way we manage this group of patients.
Methods
This was a retrospective study performed in the neu-
rosurgery ICU. There were 573 patients admitted 
to the neurosurgery ICU from January to October
2007. The subjects were 89 patients (15.53%) who had
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gastrointestinal symptoms and signs. Gastrointestinal
symptoms included abdominal pain, abdominal full-
ness, poor appetite, poor gastric emptying, poor
absorption, or unexplained back pain. Gastrointestinal
signs included ileus, ascites, abnormal stools (color,
density, texture), unknown fever, or vital sign changes
when patients were moved or their abdomens were
touched. Because of the altered consciousness of these
patients, these symptoms and signs were observed by
neurosurgery ICU staff. We collected general data
including sex, age, indications for admission to the
neurosurgery ICU, types of surgery, initial Glasgow
coma scale (GCS) score, days in the neurosurgery
ICU, and mechanical ventilator (MV)-use days. We
also collected data on vital signs (body temperature
and blood pressure), various serum markers [amylase,
lipase, hemoglobin, creatinine, albumin, alanine amino-
transferase (ALT), aspartate aminotransferase (AST),
and glucose levels], and drug prescriptions (propofol,
perdipine, steroids, and nimodipine). In indicated
patients, we performed abdominal sonography and
computed tomography (CT) to confirm the diagnosis
of pancreatitis or other pathological lesions in the
abdomen. The indications for radiological examina-
tion included highly suspected pancreatitis (symptoms,
signs, elevated amylase levels > 3-fold the upper nor-
mal limit, or elevated lipase levels > 5-fold the upper
normal limit), positive peritoneal signs, and fever of
unknown origin.
The 89 patients were categorized into Group I
and Group II by their amylase and lipase levels.
Group I included patients who had normal levels 
of pancreatic enzymes (both amylase and lipase).
Group II indicated those patients who had elevated
pancreatic enzyme levels (amylase > 190 U/L or lipase
>200U/L). We defined clinical events as the following:
anemia (hemoglobin <10mg/dL), renal failure (serum
creatinine > 1.5 mg/dL), hypotension (systolic blood
pressure < 100 mmHg), and fever (body temperature
> 38ºC).
SPSS statistical software (SPSS Inc., Chicago, IL,
USA) was used for analysis. Fisher’s exact test was used
to compare sex, mortality, hypotension, fever, anemia,
renal failure, and drug prescription of propofol, perdip-
ine, steroid, and nimodipine. For continuous measure-
ments such as age, ICU-stay days, MV-use days, initial
GCS score, minimal serum albumin levels, maximal
serum ALT/AST levels, and maximal serum glucose
levels, independent t tests or nonparametric analyses
were used. Pearson’s χ2 test was used to compare
abdominal sonography and CT findings.
Results
The patients were categorized into 2 groups; there
were 46 patients (51.7%) in Group I and 43 patients
(48.3%) in Group II. The results were analyzed in 5
parts: general data, clinical events, lab data, pre-
scribed drug effects, and radiological results.
Causes of admission
The indications for admission were divided into 8
major etiologies: subarachnoid hemorrhage, emergent
surgery, elective surgery, respiratory failure, sponta-
neous intracerebral hemorrhage, severe head injury,
spinal disease or spinal trauma, and others. Respiratory
failure due to neurological causes, such as cervical
spinal injury and severe head trauma-induced respira-
tory failure, was not included in this study. Table 1
shows the average amylase and lipase levels of neuro-
surgery ICU patients. Kruskal-Wallis tests revealed no
significant differences among the 8 groups. We found
that the average levels of pancreatic enzymes were
higher in brain insult patients compared to patients
with other causes of admission (p = 0.04).
Table 1. Mean maximal amylase/lipase levels in neurosurgery ICU patients
Diagnosis n
Amylase level, mg/dL Lipase level, mg/dL 
(p = 0.579*) (p = 0.326*)
SAH and other vascular disease 23 337.43 ± 256.49 551.86 ± 853.01
Emergent surgery 23 304.35 ± 269.98 289.55 ± 289.03
Elective surgery 17 207.65 ± 142.90 136.38 ± 135.90
Respiratory failure† 9 196.22 ± 116.94 168.33 ± 132.05
Spontaneous ICH 6 361.83 ± 252.92 853.60 ± 1,143.38
Severe head injury 5 460.40 ± 543.81 1,027.25 ± 1,642.99
Spinal disease or spinal trauma 4 151.75 ± 65.03 187.33 ± 112.61
Others‡ 2 340.50 ± 381.13 748.50 ± 972.27
*Kruskal Wallis test; †the causes of respiratory failure excluded neurological causes such as cervical spinal injury and severe head trauma; ‡others = 2 patients
who had tumor bleeding during operation and admission. ICU = intensive care unit; SAH = subarachnoid hemorrhage; ICH = intracerebral hemorrhage.
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Surgical intervention
There were 71 patients who received surgical in-
tervention in this study. Patients who received spe-
cific surgical intervention were divided into 7 major
procedures: craniotomy for trauma or intracerebral
hemorrhage aneurysm clipping or other vascular 
surgeries, craniotomy for tumors, external ventricular
drainage (EVD)/intracranial pressure monitor/ven-
triculoperitoneal shunt, spinal surgery, the transsphe-
noidal approach, and craniectomy. The average levels
of pancreatic enzymes were higher in aneurismal-
related procedures, such as clipping or external ven-
tricular drain insertion, but there was no significant
difference compared to other neurosurgical interven-
tions (Table 2).
Demographic data
There was a significant correlation between peak
amylase and lipase levels (p < 0.001; Table 3). There
were no differences in the age or sex of the patients,
initial GCS score, ICU admission days, or MV-
use days between Groups I and II. Mortality was 
significantly higher in Group II patients than in
Group I patients.
Clinical events
Group II patients had a greater incidence of anemia
and renal failure before pancreatic enzymes approached
their peak level (p < 0.05; Table 4). There were no sig-
nificant differences in incidence rates of hypotension
and fever between the 2 groups.
Serum hepatic and bile duct markers
We investigated other related serum markers because
sometimes pancreatitis is induced by hepatic or gall-
bladder disorders.2 However, there were no significant
differences in serum albumin, AST, ALT, and glucose
levels between Group I and Group II (Table 5).
Prescribed drug effects
There was no significant elevation in pancreatic
enzymes after propofol (p = 0.654), perdipine (p =
0.107), dexamethasone (p = 0.505), or nimodipine
(p = 0.582) use.
Table 2. Mean maximal amylase/lipase levels for different neurosurgical interventions
Surgery n
Amylase level, mg/dL Lipase level, mg/dL
(p = 0.380*) (p = 0.526*)
Craniotomy for trauma or ICH 20 243.75 ± 193.39 368.32 ± 644.60
Aneurysm clip or other vascular surgery 17 366.71 ± 283.18 550.53 ± 824.72
Craniotomy for tumor 14 231.29 ± 147.36 148.92 ± 148.54
EVD/ICP monitor/VP shunt 13 348.08 ± 287.91 547.08 ± 680.28
Spinal surgery 5 228.60 ± 180.83 170.00 ± 98.27
TSA† 1 104 71
Craniectomy† 1 754 313
None 18 272.72 ± 320.565 427.71 ± 851.34
*Kruskal Wallis test; †TSA and craniectomy were not listed for comparison because of the low number of samples. ICH = intracerebral hemorrhage;
EVD/ICP = external ventricular drainage/intracranial pressure; VP = ventriculoperitoneal; TSA = transsphenoidal approach.
Table 3. Demographic data*
Group I (n = 46) Group II (n = 43) p
Age (yr) 62.59 ± 14.633 61.95 ± 16.560 0.849†
Sex (male) 29 (63.0) 31 (72.1) 0.377‡
Mortality 8 (17.4) 17 (39.5) 0.033‡
ICU stay (d) 22.68 ± 19.37 25.56 ± 15.68 0.538†
MV use (d) 21.29 ± 20.56 18.86 ± 13.60 0.700†
Initial GCS score 10.72 ± 4.410 10.62 ± 3.825 0.912†
Peak amylase level (mg/dL) 118.04 ± 45.767 474.14 ± 255.592 < 0.0001†
Peak lipase level (mg/dL) 109.79 ± 83.168 687.03 ± 857.015 < 0.0001†
*Data presented as mean ± standard deviation or n (%); †independent samples t test; ‡Fisher’s exact test. ICU = intensive care unit; MV = mechanical ventila-
tor; GCS = Glasgow coma scale.
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Radiological results
Thirty-four patients received abdominal sonography
or CT (Table 6). The relationships between radiolog-
ical findings and pancreatic enzyme levels and mortal-
ity are shown in Table 7.
In a previous study of pancreatitis,2 the average amy-
lase level in a confirmed diagnosis was approximately 3
times the upper normal limit, and the average lipase
level was approximately 5 times. Therefore, we set 
3 times and 5 times as the upper normal limits of
amylase and lipase, respectively, as cut-off points 
to divide the patients into 3 groups (normal, mildly ele-
vated, and elevated pancreatic enzyme levels). When
correlating the radiological findings with the pancre-
atic enzyme levels, we found that the higher the pan-
creatic enzyme level, the more severe the radiological
finding (Tables 8 and 9).
Table 10 shows the positive (sensitivity) and nega-
tive (specificity) predictive rates for abdominal sonog-
raphy and CT in Groups I and II.
Discussion
Elevated pancreatic enzymes are frequently observed in
patients admitted to the neurosurgery ICU without
an identifiable pancreatic lesion.1,3–6 Liu et al noted
that 15% of patients had elevated serum amylase and
lipase levels at some point during their neurosurgery
ICU stay.6 Justice et al showed that 66% of patients
diagnosed with intracranial bleeding had elevated
lipase enzyme activity, and 45% had elevated amylase
enzyme activity.5 Vitale et al demonstrated that there
was a 38% prevalence of hyperamylasemia in patients
with head injury.4 In our study, we found that differ-
ent neurological indications for admission have differ-
ent percentages of elevated pancreatic enzyme levels.
Fourteen (61%) patients with subarachnoid hemor-
rhage and other vascular diseases had elevated pancre-
atic enzyme levels, as well as 11 (48%) patients who
received emergency surgery (Figure 1). We found
that patients with brain insults may have higher pan-
creatic enzyme levels compared with those with non-
brain insults. Patients with neurosurgical intervention
may have had elevated pancreatic enzymes, but there
was no significant difference in the different types of
neurosurgical intervention.
Previous studies have revealed some probable fac-
tors that are associated with elevated pancreatic
enzymes, such as Acute Physiology and Chronic
Health Evaluation (APACHE) II score, Multiple
Organ Dysfunction Score (MODS), hypotension,
fever, anemia, renal failure, total parenteral nutrition
use, MV-use days, ICU-stay days, serum transaminase
levels, total bilirubin levels, and hemoglobin levels.2
However, there were differences in neurosurgical
patients, in whom the probable factors were age, hos-
pital-stay days,6 GCS score,5 not related to shock,3
total parenteral nutrition use, drugs (steroid, manni-
tol, ceftriaxone, and nimotop),5 and mortality.6 Our
study findings were different to those from previous
studies, as discussed below.
Table 4. Clinical events*
Group I (n = 46) Group II (n = 43) p
Hypotension 25 (54.3) 16 (37.2) 0.740
Fever 16 (34.8) 25 (58.1) 0.286
Anemia 31 (67.4) 37 (86.0) 0.048†
Renal failure 4 (8.7) 12 (27.9) 0.026†
*Data presented as n (%); †Fisher’s exact test. Hypotension = systolic blood
pressure < 100 mmHg; fever = body temperature > 38°C; anemia = hemoglo-
bin < 10 mg/dL; renal failure = serum creatinine level > 1.5 mg/dL.
Table 5. Serum hepatic and bile duct markers*
Group I (n = 46) Group II (n = 43) p†
Alb level (mg/dL) 2.87 ± 0.52 2.77 ± 0.63 0.300
ALT level (mg/dL) 110.63 ± 196.86 115.38 ± 125.84 0.403
AST level (mg/dL) 76.91 ± 99.08 79.35 ± 61.24 0.242
Maximum glucose level (mg/dL) 200.11 ± 73.85 217.70 ± 112.98 0.876
*Data presented as mean ± standard deviation; †Mann-Whitney U test. Alb = albumin; ALT = alanine aminotransferase; AST = aspartate aminotransferase.
Table 6. Radiological results*
n Positive Negative
Sonography 24 4 20
Abdominal CT 14 7 7
*Four cases had both sonography and CT examination, and 9 patients were
radiologically positive. CT = computed tomography.
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Age and ICU-stay days
Only 1 report6 from a neurosurgery ward demon-
strated that the factors of age and hospital-stay days
are related to the elevation of pancreatic enzymes,
which is not similar to our study. Liu et al6 reported
that the average ages in their control group and ele-
vated pancreatic enzyme group were 45 and 58 years,
respectively. Our patients were older than in the previ-
ous study6 (the average age was 62 years, with no sig-
nificant difference between the control and experiment
groups). Age difference had little effect on elevated
pancreatic enzymes levels because of the more com-
plex medical conditions in aged patients.
In our study, elevated pancreatic enzyme levels
were not associated with ICU-stay days. We believe
that the natural course of neurological disease is differ-
ent from that of non-neurological disease. ICU-stay
days are determined by the neurological condition and
not the gastrointestinal condition. We found that the
relationship between ICU-stay days and elevated pan-
creatic enzymes was not significant.
GCS, APACHE II, and MODS score
Only 1 report5 from a neurosurgery ICU has demon-
strated that the GCS score is related to elevated pan-
creatic enzyme levels. Our results showed that there
was no relationship between GCS score and elevated
pancreatic enzyme levels. We believe that elevated
pancreatic enzyme levels are related to severity classi-
fications such as APACHE II and MODS, and are not
related to a single organ failure scale such as the GCS.
Shock
We found that shock was related to an elevation of
pancreatic enzyme levels in the general ICU, but not
in the neurosurgery ICU. Our results support the
Table 9. Amylase level versus pancreas findings on abdominal
sonography
Pancreatic enzyme level (p = 0.003*)
Sonography
Normal Mildly elevated Elevated Total
No pancreatitis 10 8 2 20
Mild pancreatitis 0 1 3 4
*Exact test.
Table 8. Amylase level versus pancreas findings on abdominal CT
Pancreatic enzyme level (p=0.007*)
CT
Normal
Mildly 
Elevated Total
elevated
No pancreatitis 3 4 0 7
Mild pancreatitis 0 4 2 6
Moderate pancreatitis 0 0 1 1
*Exact test. CT = computed tomography.
Table 7. Radiological findings versus pancreatic enzyme levels and mortality*
Radiology(+) (n = 9) Radiology(–) (n = 25) p
Maximum amylase level (mg/dL) 667.44 ± 229.42 313.44 ± 312.31 0.001†
Maximum lipase level (mg/dL) 1,550.11 ± 945.92 368.92 ± 742.08 < 0.001†
Mortality‡ 4 (44.4) 10 (40.0) 0.094§
*Data presented as mean ± standard deviation or n (%); †Mann-Whitney U test; ‡the causes of mortality for these 14 patients were brain insults or sepsis, with
no intra-abdominal events; §Pearson’s c2 test.
Table 10. Predictive rate of abdominal sonography/CT in indicated patients
Pancreatic enzyme level
Abdominal sonography (n = 24)
Normal (Group I) Elevated (Group II)
Normal pancreas 10 10
Abnormal pancreas 0 4
Predictive rate (negative/positive) 10/10 + 0 = 100% 4/14 = 28%
Pancreatic enzyme level
Abdominal CT (n = 14)
Normal (Group I) Elevated (Group II)
Normal pancreas 3 4
Abnormal pancreas 0 7
Predictive rate (negative/positive) 3/3 + 0 = 100% 7/11 = 63%
CT = computed tomography.
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findings of a previous study.4 We believe that the type
of shock found in the general ICU and the neurosur-
gical ICU is different, and neurogenic shock plays 
a major role. Warshaw and O’Hara found that the
pancreas is susceptible to shock and that hyperamy-
lasemia frequently ensues.7 It is unknown whether
hyperamylasemia results from elevated pancreatic isoen-
zymes or from salivary isoenzymes, and is still a subject
of controversy in recent research.4,7–9 We speculate that
septic shock and hypovolemic shock are the usual types
of shock in the general ICU, but neurogenic shock
plays a larger role in the neurosurgery ICU. We believe
that neurogenic shock may have no effect on elevated
pancreatic enzyme levels because the duration of shock
may not persist long enough under appropriate man-
agement. Further studies are needed to quantify auto-
nomic nerve activity to confirm the role of neurogenic
shock in elevated pancreatic enzyme levels.
Fever
The causes of fever in the general ICU are usually
infection or inflammation. However, dysfunction of
the body temperature center plays an important role
in patients, rather than the complicated infections and
other immune disorders in the general ICU. In gen-
eral, the more complicated the infection, the higher
the pancreatic enzyme levels, which fully explain why
fever is related to pancreatic enzymes in the general
ICU, but not in the neurosurgery ICU.
Relationship with hepatic and 
pancreatic diseases
To clarify the possibility of hepatic (or gallbladder 
disease) hyperamylasemia (i.e. hepatic necrosis may
decrease the clearance of amylase) or pancreatitis (i.e.
alcoholism or common bile duct stones), we also col-
lected data on serum transaminases, albumin, and
glucose levels but found no relationship to pancreatic
enzyme levels. Compared with the results from the
general ICU,2 these findings led us to believe that
elevated pancreatic enzymes are not related to
hepatic-induced hyperamylasemia or pancreatitis. In
contrast, there was stronger evidence of elevated pan-
creatic enzymes resulting from neurogenic causes.
Prescribed drug effects
Drugs had little effect on pancreatic enzyme levels in
our study, and these results are compatible with those
of a previous study5 from the neurosurgery ICU.
Although many reports have shown that the use of
propofol and steroids may result in pancreatitis,10–15
and that there is elevation of pancreatic enzyme levels,
this was not the case in our patients, since elevated pan-
creatic enzymes were largely not related to pancreatitis.
Parasympathetic motor innervations of both the
salivary glands and the pancreas control the cephalic
phase of secretion. Stimulation of the brainstem
motor nuclei of these nerves by trauma may result in
an elevation of blood amylase levels.16 Sympathetic
control of pancreatic secretion is primarily inhibitory
via vasoconstriction, which limits the maximal rate of
secretion. Loss of sympathetic tone with resultant hyper-
perfusion may result in increased amylase production
after trauma. Moreover, pancreatic polypeptide levels
in patients with severe head injury are significantly
greater than those in control trauma patients with-
out head injury.16 These peptides, including gastrin,
cholecystokinin, acetylcholine, and norepinephrine,
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Figure 1. Distribution of different indications for admission in Groups I and II patients. SAH = subarachnoid hemorrhage; ICU = intensive
care unit.
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are found in the brain and in the vagus nerve.8,17–20
Although central nervous system control of amylase
and lipase secretion is well described, how lesions of the
central nervous system lead to an elevation of amylase
and lipase is still poorly understood. Further measure-
ments and observations are needed to define whether
the autonomic nervous system is truly excited or inhib-
ited in patients with elevated pancreatic enzymes.
Our radiological results suggested that if a patient
has a serum amylase level elevated more than 3-fold
the upper normal limit or a lipase level more than 
5-fold, abdominal CT should be considered first.
Abdominal sonography can also be performed if the
patient’s condition does not permit CT examination.
The typical radiological findings in our neurosurgical
patients were mild pancreatitis features, which agree
with the mildly elevated pancreatic enzymes. Consid-
ering the benefit of enteral nutrition, we suggest con-
tinuing feeding if amylase levels are less than 3-fold
the upper normal limit and lipase levels are less than
5-fold, and then following up the levels of pancreatic
enzymes until pancreatic enzyme levels have declined.
This retrospective study had selection bias. Gastro-
intestinal symptoms and signs were determined by the
doctors and nurses because of patients’ altered level
of consciousness. Many symptoms were nonspecific,
such as “unexplained back pain” and “unknown fever”.
A more rigorous study design would be a prospective
laboratory evaluation of all admissions to the neurosur-
gery ICU to determine if there are differences between
patients with normal serum pancreatic enzyme levels
and elevated levels.
In conclusion, elevated pancreatic enzyme levels in
the neurosurgery ICU are a complicated condition.
Nearly half of the patients admitted to the neurosurgery
ICU with gastrointestinal signs had elevated serum
pancreatic enzyme levels. Mildly elevated pancreatic
enzymes were rarely caused by pancreatitis in the neuro-
surgery ICU. Various neurosurgical events and diag-
noses may lead to a different extent of elevation of
serum pancreatic enzymes. This finding was related to
anemia and renal failure, but was not related to age,
sex, admission stay, MV-use days, GCS score, hypoten-
sion and fever. Drug effects were minimal. A higher
mortality rate was present in patients with elevated
pancreatic enzyme levels. We suggest that abdominal
CT should be indicated for patients if their amylase
levels are more than 3-fold and lipase levels are more
than 5-fold the upper normal limits.
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